357 related articles for article (PubMed ID: 14678277)
1. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?
Muratori P; Muratori L; Gershwin ME; Czaja AJ; Pappas G; MacCariello S; Granito A; Cassani F; Loria P; Lenzi M; Bianchi FB
Clin Exp Immunol; 2004 Jan; 135(1):154-8. PubMed ID: 14678277
[TBL] [Abstract][Full Text] [Related]
2. Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up.
Csepregi A; Szodoray P; Zeher M
Scand J Immunol; 2002 Dec; 56(6):623-9. PubMed ID: 12472675
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis.
Tanaka A; Miyakawa H; Luketic VA; Kaplan M; Storch WB; Gershwin ME
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):295-9. PubMed ID: 12030434
[TBL] [Abstract][Full Text] [Related]
6. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
[TBL] [Abstract][Full Text] [Related]
7. Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?
Comay D; Cauch-Dudek K; Hemphill D; Diamandis E; Wanless I; Heathcote EJ
Dig Dis Sci; 2000 Oct; 45(10):2018-21. PubMed ID: 11117577
[TBL] [Abstract][Full Text] [Related]
8. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
[TBL] [Abstract][Full Text] [Related]
9. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
[TBL] [Abstract][Full Text] [Related]
10. Detection of serum M2 anti-mitochondrial antibodies by enzyme-linked immunosorbent assay is potentially less specific than by immunofluorescence.
Patel D; Egner W; Gleeson D; Wild G; Ward A
Ann Clin Biochem; 2002 May; 39(Pt 3):304-7. PubMed ID: 12038605
[TBL] [Abstract][Full Text] [Related]
11. [The significance of antimitochondrial IgA and IgG in the diagnosis of primary biliary cirrhosis].
Lu JX; Qian SY; Shu X; Li G
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):905-9. PubMed ID: 20038331
[TBL] [Abstract][Full Text] [Related]
12. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies.
Nakanuma Y; Harada K; Kaji K; Terasaki S; Tsuneyama K; Moteki S; Van de Water J; Leung PS; Gershwin ME
Liver; 1997 Dec; 17(6):281-7. PubMed ID: 9455733
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic features of primary biliary cirrhosis in AMA-positive and AMA-negative patients.
Fujioka S; Yamamoto K; Okamoto R; Miyake M; Ujike K; Shimada N; Terada R; Miyake Y; Nakajima H; Piao CY; Iwasaki Y; Tanimizu M; Tsuji T
Endoscopy; 2002 Apr; 34(4):318-21. PubMed ID: 11932789
[TBL] [Abstract][Full Text] [Related]
15. [Western blot analysis of anti-M2 antibodies in anti-mitochondrial antibody-negative primary biliary cirrhosis].
Kawaguchi N; Miyakawa H; Abe K; Kitazawa E; Fujikawa H; Kikuchi K; Kako M; Shibata M; Shibuya A; Onozuka Y; Yoshida N; Ueno Y
Rinsho Byori; 1997 Nov; 45(11):1079-84. PubMed ID: 9396349
[TBL] [Abstract][Full Text] [Related]
16. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.
Kadokawa Y; Omagari K; Hazama H; Ohba K; Masuda J; Kinoshita H; Hayashida K; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
Clin Biochem; 2003 May; 36(3):203-10. PubMed ID: 12726929
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.
Juliusson G; Imam M; Björnsson ES; Talwalkar JA; Lindor KD
Scand J Gastroenterol; 2016; 51(6):745-52. PubMed ID: 26776319
[TBL] [Abstract][Full Text] [Related]
19. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis.
Kitami N; Komada T; Ishii H; Shimizu H; Adachi H; Yamaguchi Y; Kitamura T; Oide H; Miyazaki A; Ishikawa M
Intern Med; 1995 Jun; 34(6):496-501. PubMed ID: 7549131
[TBL] [Abstract][Full Text] [Related]
20. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
